Skip to main content

Table 1 Clinical characteristics of the study population in the control, ACVIM B and ACVIM C groups

From: Plasma miRNAs as potential biomarkers of chronic degenerative valvular disease in Dachshunds

ACVIM stage ACVIM A–unaffected (mean ± SD) ACVIM B (mean ± SD) ACVIM C (mean ± SD)
Numer of dogs 8 8 7
Age range (years) 5.458 ± 2.51 10.17 ± 3.36 10.40 ± 4.73
Sex Males 2 4 5
Females 6 4 3
Body weight (kg) 10.38 ± 3.26 9.46 ± 2.13 9.20 ± 1.83
EF % 71.25 ± 12.26 69.5 ± 8.21 77.14 ± 3.39
LA/Ao 1.223 ± 0.10 1.479 ± 0.41 1.774 ± 0.21*
LA cm 1.938 ± 0.47 2.348 ± 0.54 2.811 ± 0.32*
LVDd 2.863 ± 0.24 2.993 ± 0.43 3.529 ± 0.42**
MVR 0 5.466 ± 1.05*** (n = 5) 5.963 ± 0.78***
RVDd 0.9375 ± 0.17 0.9275 ± 0.14 0.6057 ± 0.21**
TVR m/s 0.3988 ± 1.13 0.925 ± 1.39 2.379 ± 1.19*
  1. *statistically significant difference vs healthy dogs with p < 0.05; **statistically significant difference vs healthy dogs with p < 0.01; ***statistically significant difference vs healthy dogs with p < 0.001.